Scientists have successfully engineered the most complicated human cell lines ever, indicating that our genomes are more tolerant to significant structural alterations than previously assumed.

In 2019, the first CRISPR clinical trials were conducted to treat sickle cell diseases and in 2020, this treatment was ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...

Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results ...

The X contains more genes related to brain function than does any other chromosome. “The X chromosome may be a treasure trove of genes that influence cognition, and these could be therapeutic targets, ...

AlleyWatch sat down with Nucleus CEO and Founder Kian Sadeghi to learn more about the business, its future plans, and recent ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer of Beam, plans to ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot ...